Search Results 781-790 of 15965 for melatonin receptor agonists
... agonist goserelin. Patients must have commenced treatment with goserelin or an alternative LHRH agonist at least 28 days prior to first dose of treatment.
Has previously received any CGRP ligand or receptor targeted monoclonal antibody. Eligibility last updated 1/19/22. Questions regarding updates should be ...
About this study. Aims, purpose, or objectives: Develop a retrospective registry of patients with cardiac sarcoidosis; Develop a prospective registry of ...
Octreotide is used for the long-term treatment of acromegaly (a growth hormone disorder) in patients who have been previously treated with octreotide or ...
Jacksonville, Fla. The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the ...
The purpose of this study is to determine whether treatment of obstructive sleep apnea (OSA) with positive airway pressure starting shortly after acute ...
Type: Fellowship; Duration: 1-2 years; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...
About this study. To further investigate biomarkers in CSF as possible predictors for mild cognitive impairment and dementia ...
The Memory Disorders Lab led by Neill R. Graff-Radford, M.D., at Mayo Clinic is focused on clinicopathological studies to identify those at risk of ...
Latanoprost eye drops is used to treat certain kinds of glaucoma. It is also used to treat a condition called hypertension of the eyealone or together with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.